We are live on
!
Find out more
ATXS
Astria Therapeutics
ATXS
ATXS
Delisted
ATXS was delisted on the 22nd of January, 2026.
115 hedge funds and large institutions have $409M invested in Astria Therapeutics in 2025 Q3 according to their latest regulatory filings, with 20 funds opening new positions, 33 increasing their positions, 39 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more ownership
Funds ownership: →
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
15% less repeat investments, than reductions
Existing positions increased: 33 | Existing positions reduced: 39
19% less call options, than puts
Call options by funds: $327K | Put options by funds: $406K
Holders
115
Holding in Top 10
1
Calls
$327K
Puts
$406K
Top Buyers
| 1 | +$10.4M | |
| 2 | +$2.94M | |
| 3 | +$2.29M | |
| 4 |
Jane Street
New York
|
+$982K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$795K |
Top Sellers
| 1 | -$8.83M | |
| 2 | -$2.21M | |
| 3 | -$1.71M | |
| 4 |
BlackRock
New York
|
-$1.42M |
| 5 |
LGM
Logos Global Management
San Francisco,
California
|
-$1.35M |